Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

Trigo, José Manuel; Garcia-Cosio, Monica; García‑Castaño, Almudena; Gomà, Montserrat; Mesia, Ricard; Ruiz‑Bravo, Elena; Braña Garcia, Irene; Alberola Ferranti, Margarita

dc.contributor	Departament de Salut
dc.contributor.author	Trigo, José Manuel
dc.contributor.author	Garcia-Cosio, Monica
dc.contributor.author	García‑Castaño, Almudena
dc.contributor.author	Gomà, Montserrat
dc.contributor.author	Mesia, Ricard
dc.contributor.author	Ruiz‑Bravo, Elena
dc.contributor.author	Braña Garcia, Irene
dc.contributor.author	Alberola Ferranti, Margarita
dc.date.accessioned	2022-09-12T09:54:26Z
dc.date.available	2022-09-12T09:54:26Z
dc.date.issued	2022-10
dc.identifier.citation	Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, et al. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clin Transl Oncol. 2022 Oct;24:1890–902.
dc.identifier.issn	1699-3055
dc.identifier.uri	https://hdl.handle.net/11351/8153
dc.description	Virus d'Epstein Barr; Pronòstic; Resposta al tractament
dc.description.sponsorship	SEOM and SEAP acknowledge the financial support for this project in the form of unrestricted collaboration in the logistics from AstraZeneca.
dc.language.iso	eng
dc.publisher	Springer
dc.relation.ispartofseries	Clinical and Translational Oncology;24
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Marcadors bioquímics
dc.subject	Glàndules salivals - Càncer
dc.subject	Cap - Càncer
dc.subject.mesh	Head and Neck Neoplasms
dc.subject.mesh	Salivary Gland Neoplasms
dc.subject.mesh	Biomarkers, Tumor
dc.title	Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1007/s12094-022-02856-1
dc.subject.decs	neoplasias de cabeza y cuello
dc.subject.decs	neoplasias de las glándulas salivales
dc.subject.decs	marcadores tumorales
dc.relation.publishversion	https://doi.org/10.1007/s12094-022-02856-1
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Trigo J] HC Marbella International Hospital, Spanish Society of Medical Oncology (SEOM), Marbella, Spain. [García-Cosío M] Ramón y Cajal University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [García-Castaño A] Marqués de Valdecilla University Hospital, Spanish Society of Medical Oncology (SEOM), Santander, Spain. [Gomà M] Bellvitge University Hospital, Spanish Society of Pathological Anatomy (SEAP), Hospitalet de Llobregat, Spain. [Mesia-Nin R] Catalan Institute of Oncology (ICO), Badalona Applied Research Group in Oncology, Germans Trias i Pujol Research Institute, Spanish Society of Medical Oncology (SEOM), Badalona, Spain. [Ruiz-Bravo E] La Paz University Hospital, Spanish Society of Pathological Anatomy (SEAP), Madrid, Spain. [Braña-García I] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Society of Medical Oncology (SEOM), Barcelona, Spain. [Alberola-Ferranti M] Vall d’Hebron Hospital Universitari, Spanish Society of Pathological Anatomy (SEAP), Barcelona, Spain
dc.identifier.pmid	35739348
dc.identifier.wos	000814957700002
dc.rights.accessrights	info:eu-repo/semantics/openAccess